Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Dexcom (DXCM)

Dexcom Q2 revenue rises 15% to $1.157 billion; raises 2025 revenue guidance

Positive Impact 4 of 5 earnings Written later

Dexcom reported second-quarter 2025 revenue of $1.157 billion, up 15% year over year, and GAAP net income of $179.8 million, or $0.45 per diluted share, versus $143.5 million, or $0.35, a year earlier. The company raised its 2025 revenue guidance to $4.600 to $4.625 billion, and CEO Kevin Sayer will retire effective January 1, 2026, with President and COO Jake Leach succeeding him.

Key points

  • Q2 2025 revenue: $1.157 billion, up 15% year over year; U.S. revenue up 15% and international revenue up 16%
  • GAAP diluted EPS $0.45 vs. $0.35 in Q2 2024; non-GAAP operating margin 19.2%, down 30 basis points from Q2 2024
  • 2025 revenue guidance raised to $4.600 to $4.625 billion (14% to 15% growth); other margin guidance reiterated
  • Jake Leach to become CEO and a director effective January 1, 2026; Kevin Sayer to remain executive chairman

The filing

CompanyDexcom (DXCM)
Form8-K, current report
Filed with the SECJul 30, 2025, 4:02 PM ET
Accession number0001093557-25-000241

Items reported: 2.02 Results of Operations5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:10 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2025.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.